DNV capital
Asia, Guangdong, China, Shenzhen'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
DNV capital is an international venture capital firm focusing on the investments in healthcare and innovative technology industry.
Investor Profile
DNV capital has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 17% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series E, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States, China, Israel.
- Strong thematic focus on Health Care, Medical, Medical Device.
Stage Focus
- Series E (33%)
- Series C (33%)
- Series B (33%)
Country Focus
- United States (50%)
- China (33%)
- Israel (17%)
Industry Focus
- Health Care
- Medical
- Medical Device
- Biotechnology
- Pharmaceutical
- Manufacturing
- Health Diagnostics
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
